BioSig Technologies Inc. (BSGM)
BioSig Statistics
Share Statistics
BioSig has 24.25M shares outstanding. The number of shares has increased by 63.15% in one year.
| Shares Outstanding | 24.25M |
| Shares Change (YoY) | 63.15% |
| Shares Change (QoQ) | 33.68% |
| Owned by Institutions (%) | 50.5% |
| Shares Floating | 18.86M |
| Failed to Deliver (FTD) Shares | 619 |
| FTD / Avg. Volume | 0.2% |
Short Selling Information
The latest short interest is 425.48K, so 1.75% of the outstanding shares have been sold short.
| Short Interest | 425.48K |
| Short % of Shares Out | 1.75% |
| Short % of Float | 2.12% |
| Short Ratio (days to cover) | 4.83 |
Valuation Ratios
The PE ratio is -20.25 and the forward PE ratio is 0.93. BioSig's PEG ratio is 0.25.
| PE Ratio | -20.25 |
| Forward PE | 0.93 |
| PS Ratio | 5230.55 |
| Forward PS | 0.4 |
| PB Ratio | -147.13 |
| P/FCF Ratio | -43.97 |
| PEG Ratio | 0.25 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for BioSig.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.15, with a Debt / Equity ratio of -0.07.
| Current Ratio | 0.15 |
| Quick Ratio | 0.15 |
| Debt / Equity | -0.07 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.02 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $8K |
| Profits Per Employee | $-2.07M |
| Employee Count | 5 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 174K |
| Effective Tax Rate | -1.68% |
Stock Price Statistics
The stock price has increased by -48.74% in the last 52 weeks. The beta is 0.8, so BioSig's price volatility has been higher than the market average.
| Beta | 0.8 |
| 52-Week Price Change | -48.74% |
| 50-Day Moving Average | 0.72 |
| 200-Day Moving Average | 0.86 |
| Relative Strength Index (RSI) | 67.1 |
| Average Volume (20 Days) | 315.44K |
Income Statement
In the last 12 months, BioSig had revenue of 40K and earned -10.33M in profits. Earnings per share was -0.07.
| Revenue | 40K |
| Gross Profit | 40K |
| Operating Income | -12.86M |
| Net Income | -10.33M |
| EBITDA | -12.42M |
| EBIT | -12.61M |
| Earnings Per Share (EPS) | -0.07 |
Balance Sheet
The company has 142K in cash and 102K in debt, giving a net cash position of 40K.
| Cash & Cash Equivalents | 142K |
| Total Debt | 102K |
| Net Cash | 40K |
| Retained Earnings | -255.34M |
| Total Assets | 842K |
| Working Capital | -1.92M |
Cash Flow
In the last 12 months, operating cash flow was -4.76M and capital expenditures 0, giving a free cash flow of -4.76M.
| Operating Cash Flow | -4.76M |
| Capital Expenditures | 0 |
| Free Cash Flow | -4.76M |
| FCF Per Share | -0.03 |
Margins
Gross margin is 100%, with operating and profit margins of -32155% and -25825%.
| Gross Margin | 100% |
| Operating Margin | -32155% |
| Pretax Margin | -25847.5% |
| Profit Margin | -25825% |
| EBITDA Margin | -31052.5% |
| EBIT Margin | -32155% |
| FCF Margin | -11895% |
Dividends & Yields
BSGM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for BSGM is $2.5, which is 145.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.5 |
| Price Target Difference | 145.1% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Feb 2, 2024. It was a backward split with a ratio of 1:10.
| Last Split Date | Feb 2, 2024 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -465.76 |
| Piotroski F-Score | 4 |